Biosimilars in der Anämietherapie – Sicherheit und Wirksamkeit von Epoetin zeta in klinischen Studien belegt

Literatur

• 01 Wizemann V , Rutkowski B , Baldamus C , et al . Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.  Curr Med Res Opin. 2008;  24 625-637
• 02 Krivoshiev S , Todorov V V, Manitius J , et al . Comparison of the therapeutic effects of epoetin zeta and epoetin alpha in the correction of renal anaemia.  Curr Med Res and Opin. 2008;  24 1407-1415
• 03 Baldamus C , Krivoshiev S , Wolf-Pflugmann M , et al . Long-term safety and tolerability of epoetin zeta, administered intravenously, for maintenance treatment of renal anemia.  Adv Ther. 2008;  25 1215-1228
• 04 Krivoshiev S , Wizemann V , Czekalski S , et al . Therapeutic equivalence of epoetin zeta and alfa, administered subcutaneously, for maintenance treatment of renal anemia.  Adv Ther. 2010;  27 105-117
• 05 Tzekova V , Mihaylov G , Elezovic I , et al . Therapeutic effects of epoetin zeta in the treatment of chemotherapy-induced anaemia.  Curr Med Res Opin. 2009;  25 1689-1697
• 06 Mucsi I , Molnar M Z, Ambrus C , et al . Restless legs syndrome, insomnia and quality of life in patients on maintenance dialysis.  Nephrol Dial Transplant. 2005;  20 571-577